Viewing Study NCT02302833


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2026-03-03 @ 10:17 AM
Study NCT ID: NCT02302833
Status: COMPLETED
Last Update Posted: 2025-07-31
First Post: 2014-11-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery
Sponsor: M.D. Anderson Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-02-17
Start Date Type: ACTUAL
Primary Completion Date: 2024-11-12
Primary Completion Date Type: ACTUAL
Completion Date: 2024-11-12
Completion Date Type: ACTUAL
First Submit Date: 2014-11-21
First Submit QC Date: None
Study First Post Date: 2014-11-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2025-07-11
Results First Submit QC Date: None
Results First Post Date: 2025-07-31
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-11
Last Update Post Date: 2025-07-31
Last Update Post Date Type: ACTUAL